MeVis Medical Solutions AG (ETR:M3V)

Market Cap	47.32M
Revenue (ttm)	16.64M
Net Income (ttm)	4.30M
Shares Out	1.82M
EPS (ttm)	2.36
PE Ratio	11.00
Forward PE	n/a
Dividend	0.95 (3.65%)
Ex-Dividend Date	Mar 26, 2025

Volume	13
Average Volume	182
Open	25.60
Previous Close	26.00
Day's Range	25.60 - 26.00
52-Week Range	23.80 - 26.80
Beta	-0.19
RSI	74.87
Earnings Date	Jan 29, 2026

About ETR:M3V

MeVis Medical Solutions AG develops, markets, and sells software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imagi...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 114
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: M3V

Financial Performance

In 2024, ETR:M3V's revenue was 16.97 million, a decrease of -2.14% compared to the previous year's 17.34 million. Earnings were 4.56 million, a decrease of -7.29%.